The Hidden Cost of Skipping Frailty Assessment: New Research Reveals

The Hidden Cost of Skipping Frailty Assessment: New Research Reveals Please like and subscribe if you enjoyed this video :-)     Introduction Frailty assessment remains critically underutilized in healthcare settings despite affecting approximately 15% of noninstitutionalized adults in the United States

GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped? A Critical Analysis

GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped? A Critical Analysis Please like and subscribe if you enjoyed this video :-)    Abstract The treatment landscape for managing weight in non-diabetic patients has changed dramatically with the introduction of

The Hidden Cost of Skipping Frailty Assessment: New Research Reveals